Pharmacists in Kingston, Rhode Island


11 Pharmacists found in Kingston
female pharmacist

Anita N Jacobson, PHAM.D.


Pharmacist - Pharmacotherapy
7 Greenhouse Rd, 295b, Kingston, RI 02881
401-874-2641     401-874-5670

male pharmacist

Brett M Feret, PHARMD


Pharmacist
41 Lower College Road, 144 Fogarty Hall, Kingston, RI 02881
401-874-5522    

male pharmacist

Dr. E Paul Larrat, R.PH., PH.D.


Pharmacist
7 Greenhouse Rd, Kingston, RI 02881
401-874-5003    



female pharmacist

Dr. Katherine Kelly Orr, PHARMD


Pharmacist
University Of Rhode Island College Of Pharmacy, 44 Lower College Rd., Kingston, RI 02881
401-874-5522    

female pharmacist

Lisa G. Mcandrews-morin, RPH,BCGP,CDOE,CVDOE


Pharmacist
7 Greenhouse Rd #265d, Pharmacy Outreach Dept. (per Diem Practice Location), Kingston, RI 02881
401-486-8697    

male pharmacist

Dr. Matthew Mitchell Lacroix, PHARM.D RPH


Pharmacist - Pharmacotherapy
7 Greenhouse Rd, Kingston, RI 02881
401-874-5023    

female pharmacist

Dr. Michelle L Thomas, PHARMD, BCPS, BCACP


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
7 Greenhouse Rd, Uri College Of Pharmacy, Kingston, RI 02881
401-874-1000    

female pharmacist

Dr. Natalya Sergeyevna Salganik, PHARMD


Pharmacist
7 Greenhouse Rd, Kingston, RI 02881
401-874-2761    

female pharmacist

Nikki Anne Mcpeak, RPH, CDOE, CVDOE



3 Mark Glen Ct, Kingston, RI 02881
401-741-9250    

male pharmacist

Dr. Patrick Stephen Kelly, PHARMD


Pharmacist
7 Greenhouse Rd, Kingston, RI 02881
401-874-4027    

male pharmacist

Robert Breslin, RPH


Pharmacist
25 Roberts Ct, Kingston, RI 02881
401-742-2098    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.